Discover six of the top psychedelic companies developing novel drugs to expand the treatment scope for mental health ...

Discover why some biotechs fail but survive with cash on hand, and how players like Concentra are trying to unlock trapped ...

This past year has seen various developments in the field of oncolytic virus therapies - in fundraising and in the clinic.

Learn about July 2025’s top biotech deals, featuring major collaborations in small molecules, antibodies, and drug delivery.

Abivax, MapLight Therapeutics, Everest Medicines, and Soleno Therapeutics bagged the biggest biotech funding rounds overall ...

Fusion proteins have drawn investors these past months attracting dollars from deep pockets in the pursuit of commercial success.

New narcolepsy treatments are being tested in the clinic, and recently, some of them have made promising strides. How far along are they?

NATO Innovation Fund backs Portal Biotech in its first biotech move. What does this signal for strategic investment in healthcare innovation?

Five acquisitions in 2025—including Cargo and Allakos—have put Concentra Biosciences in the spotlight. Learn what’s behind the strategy.